SkyAI, Inc.
SKYANasdaq
$1.16
↓ -2.5%Jul 17 close · end-of-day
Price
1Y↓ -80.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$84.2M
Enterprise Value
$71.9M
P/E
—
P/S
—
P/B
0.5
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
-$370.7M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-207.3%
ROIC
-168.3%
Debt / Equity
—
Net Cash
$12.3M
Return 1Y
-80.0%
Company profile
Sharps Technology Inc. researches, designs, develops, manufactures, distributes, and sells safety syringe products. Sharps Provensa is an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
- CEO
- Robert M. Hayes
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 3
- Headquarters
- New York
- Website
- sharpstechnology.com
Management & directors
- Crescenzo Andrew R.Chief Financial Officer
Roles derived from SEC Form 4 filings.
Earnings
SKYA Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$192,780.00—
Diluted EPS-$1.19↓ -103.1%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | $204,120.00 |
| Gross profit | — | — | — | — | -$413,325.00 |
| Operating income | -$4.5M | -$8.7M | -$10.1M | -$5.6M | -$269.7M |
| Net income | -$4.7M | -$4.6M | -$9.8M | -$9.3M | -$282.5M |
| Diluted EPS | — | -$0.57 | -$16.61 | -$2,219.92 | -$11.16 |
| Operating cash flow | -$3.1M | -$6.4M | -$8.5M | -$4.4M | -$11.0M |
| Free cash flow | -$5.4M | -$7.0M | -$9.2M | -$4.5M | — |
| Gross margin | — | — | — | — | -202.5% |
| Operating margin | — | — | — | — | -132145.5% |
| Net margin | — | — | — | — | -138400.0% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $222,722.00 | $83,622.00 | — | $192,780.00 |
| Gross profit | — | — | — | — | -$1.0M | -$1.2M | — | -$9,798.00 |
| Operating income | -$1.9M | -$2.0M | $212,762.00 | -$1.4M | -$3.0M | -$102.6M | -$162.7M | -$86.3M |
| Net income | -$2.1M | -$1.7M | -$4.5M | $1.9M | $3.6M | -$105.3M | -$182.7M | -$86.2M |
| Diluted EPS | -$643.64 | -$379.55 | -$849.23 | $38.63 | $3.58 | -$4.33 | -$49.04 | -$1.19 |
| Operating cash flow | -$1.6M | -$1.6M | $770,743.00 | -$1.4M | -$2.9M | -$7.4M | $752,877.00 | -$2.7M |
| Free cash flow | -$1.7M | -$1.7M | $701,598.00 | -$1.5M | -$4.8M | -$8.8M | — | — |
| Gross margin | — | — | — | — | -463.4% | -1398.7% | — | -5.1% |
| Operating margin | — | — | — | — | -1349.8% | -122747.9% | — | -44748.4% |
| Net margin | — | — | — | — | 1598.1% | -125963.6% | — | -44734.5% |
Company news
May 14, 2026
Feb 7, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-01-16 | Saba Capital Management, L.P. | Sale | 12,182 | $2.37 | $28,871.34 | filing |
| 2026-01-15 | Saba Capital Management, L.P. | Sale | 25,000 | $2.30 | $57,500.00 | filing |
| 2026-01-14 | Saba Capital Management, L.P. | Sale | 77,688 | $2.25 | $174,798.00 | filing |
| 2026-01-13 | Saba Capital Management, L.P. | Sale | 29,777 | $2.19 | $65,211.63 | filing |
| 2026-01-12 | FalconX Holdings Ltd | Sale | 192,307 | $1.97 | $377,940.95 | filing |
| 2026-01-12 | FalconX Holdings Ltd | Sale | 47,281 | $1.97 | $92,921.35 | filing |
| 2026-01-09 | FalconX Holdings Ltd | Sale | 269,321 | $1.93 | $518,523.72 | filing |
| 2026-01-09 | FalconX Holdings Ltd | Sale | 260,411 | $1.93 | $501,369.30 | filing |
| 2026-01-09 | FalconX Holdings Ltd | X | 461,538 | $0.00 | $46.15 | filing |
| 2025-08-27 | Ruemler Timothy James | Sale | 5,000 | $17.09 | $85,461.00 | filing |
| 2025-08-27 | Ruemler Timothy James | Sale | 5,000 | $16.75 | $83,750.00 | filing |
| 2025-08-27 | Ruemler Timothy James | Sale | 5,000 | $16.58 | $82,875.00 | filing |
| 2025-08-27 | Ruemler Timothy James | Sale | 5,000 | $16.54 | $82,700.00 | filing |
| 2025-08-25 | Ruemler Timothy James | Buy | 5,000 | $12.50 | $62,500.00 | filing |
| 2025-08-25 | Ruemler Timothy James | Buy | 5,000 | $12.48 | $62,400.00 | filing |
| 2025-08-25 | Ruemler Timothy James | Buy | 5,000 | $12.00 | $60,000.00 | filing |
| 2025-08-25 | Ruemler Timothy James | Buy | 5,000 | $11.84 | $59,200.00 | filing |
| 2025-08-25 | Ruemler Timothy James | Buy | 5,000 | $11.22 | $56,100.00 | filing |
| 2025-08-25 | Ruemler Timothy James | Buy | 5,000 | $10.63 | $53,167.50 | filing |
| 2025-08-25 | Ruemler Timothy James | Buy | 5,000 | $10.50 | $52,500.00 | filing |
| 2025-08-25 | Ruemler Timothy James | Buy | 4,682 | $9.69 | $45,368.58 | filing |
| 2025-08-25 | Ruemler Timothy James | Buy | 118 | $9.63 | $1,136.34 | filing |
| 2025-08-25 | Ruemler Timothy James | Buy | 100 | $9.69 | $969.00 | filing |
| 2025-08-25 | Ruemler Timothy James | Buy | 100 | $9.60 | $960.00 | filing |
| 2025-08-22 | DANNER PAUL K | Buy | 400,000 | $6.41 | $2.6M | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.